DigestRedComo funciona
Red
/
Empresas
Co
No verificado

Cofactor Genomics, Inc.

Sobre qué escribimos

BiotecnologíaCienciaOncologíaSaludSanidad

6 Comunicados de prensa

Ver todos los comunicados de prensa
12/02/2025
Técnica
Ciencia
Biotecnología
Salud
Sanidad
Oncología
Análisis de Mercados
Industria
Cofactor Genomics Publishes Analytical Validation of OncoPrism-HNSCC, Highlighting Robustness of The AI-powered RNA Test In Predicting Cancer Patient Response To Immunotherapy
Fuente
Cofactor Genomics, Inc.
Editor
Business Wire
1.00
0
08/01/2025
Mercado laboral
Ciencia
Finanzas
Medicina - Varios
Asociaciones/Profesionales
Biotecnología
Farmacéutica
Salud
Oncología
Cofactor Genomics, Inc. Announces CEO Transition in Preparation for Accelerated Commercial Growth and Increased Patient Access for OncoPrism, its Medicare Approved Immunotherapy Test
Fuente
Cofactor Genomics, Inc.
Editor
Business Wire
1.00
0
15/11/2024
Ciencia
Técnica
Biotecnología
Sanidad
Salud
Oncología
Cofactor Genomics expands clinical use of OncoPrism, as their AI enabled RNA test achieves national clinical validation after predicting immunotherapy response in Lung Cancer Patients
Fuente
Cofactor Genomics, Inc.
Editor
Business Wire
1.00
0
07/11/2024
Industria
Ciencia
Sanidad
Oncología
Material médico sanitario
Biotecnología
Medicina - Varios
Salud
Cofactor Genomics Publishes Clinical Validation of OncoPrism-HNSCC, a Test Leveraging Novel RNA Modeling Technology to Predict Response to Immunotherapy
Fuente
Cofactor Genomics, Inc.
Editor
Business Wire
1.00
0
29/10/2024
Mercado laboral
Ciencia
Sanidad
Biotecnología
Medicina - Varios
Farmacéutica
Salud
Precision Medicine Global Thought Leader, Dr. Howard McLeod, Joins Cofactor Genomics’ Advisory Board as Cofactor Brings OncoPrism test to Partnered Hospitals
Fuente
Cofactor Genomics, Inc.
Editor
Business Wire
1.00
0
18/10/2024
Ciencia
Sanidad
Asociaciones/Profesionales
Farmacéutica
Oncología
Finanzas
Biotecnología
Medicina - Varios
Salud
Cofactor Genomics receives Medicare coverage for OncoPrism®, a machine learning-based RNA oncology test predicting immunotherapy response
Fuente
Cofactor Genomics, Inc.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0